UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
74 hedge funds and large institutions have $127M invested in Unity Biotechnology in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 23 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
6% less funds holding
Funds holding: 79 → 74 (-5)
19% less capital invested
Capital invested by funds: $157M → $127M (-$30.1M)
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
Holders
74
Holding in Top 10
2
Calls
$122K
Puts
$1K
Top Buyers
| 1 | +$5.22M | |
| 2 | +$862K | |
| 3 | +$759K | |
| 4 |
Renaissance Technologies
New York
|
+$664K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$263K |
Top Sellers
| 1 | -$2.13M | |
| 2 | -$1.58M | |
| 3 | -$994K | |
| 4 |
Morgan Stanley
New York
|
-$929K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$380K |